Moderna is redefining pandemic preparedness through its cutting-edge mRNA platform, enabling faster, more adaptable vaccine development for emerging infectious threats. By combining scientific innovation with global partnerships and decentralized manufacturing, the company is working to ensure timely and equitable access to next-generation vaccines worldwide.